FDA Inspection 1261727 — Somerset Therapeutics Private Limited
The FDA completed an inspection of Somerset Therapeutics Private Limited on Feb 21, 2025 in Bengaluru. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Feb 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)